Most cited papers from Pharis Biotec (Germany)

Pharis Biotec (Germany)

What are the most cited papers from Pharis Biotec (Germany)?

The most cited paper from Pharis Biotec (Germany) is "Discovery and Characterization of an Endogenous CXCR4 Antagonist" (Onofrio Zirafi et al., 2015), with 104 citations. Next come "A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins" (89) and "Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide" (85).

Published TypeFieldAccess

Showing 25 of 25 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Discovery and Characterization of an Endogenous CXCR4 Antagonist Onofrio Zirafi et al. · Cell Reports Open access	25 Apr 2015	104
2	A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins Steve Peigneur, László Béress, Carolina Möller et al. · The FASEB Journal	12 Sep 2012	89
3	Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide Wolf‐Georg Forssmann, Yu-Han The, Matthias Stoll et al. · Science Translational Medicine	22 Dec 2010	85
4	Immunotherapy of patients with hormone‐refractory prostate carcinoma pre‐treated with interferon‐gamma and vaccinated with autologous PSA‐peptide loaded dendritic cells—A pilot study Bernd Hildenbrand, Brian C. Sauer, O. Kalis et al. · The Prostate	29 Jan 2007	56
5	Challenging the “gold standard” of colony-forming units - Validation of a multiplex real-time PCR for quantification of viable Campylobacter spp. in meat rinses Kerstin Stingl et al. · International Journal of Food Microbiology Open access	24 Sep 2021	36
6	A Placenta Derived C-Terminal Fragment of β-Hemoglobin With Combined Antibacterial and Antiviral Activity Rüdiger M. Groß et al. · Frontiers in Microbiology Open access	6 Apr 2020	30
7	Unbiased Identification of Angiogenin as an Endogenous Antimicrobial Protein With Activity Against Virulent Mycobacterium tuberculosis Reiner Noschka, Fabian Gerbl, Florian Löffler et al. · Frontiers in Microbiology Open access	18 Jan 2021	26
8	Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling Manuel Hayn, Andrea Blötz, Armando Rodríguez et al. · Proceedings of the National Academy of Sciences Open access	11 Jan 2021	22
9	Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes Thomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin et al. · Kidney & Blood Pressure Research Open access	2015	19
10	Synthesis of the proteinase inhibitor LEKTI domain 6 by the fragment condensation method and regioselective disulfide bond formation Zoe Vasileiou, Kostas K. Barlos, Kostas K. Barlos et al. · Biopolymers	2010	18
11	Protransduzin™ - A novel transduction enhancer to accelerate en gros CAR-T production Ana F. Castro, Michael Drosch, M. Liesenfeld et al. · Cytotherapy	May 2019	13
12	Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis Felix Immanuel Maier, David Klinger, Mark Grieshober et al. · Medical Microbiology and Immunology Open access	20 Jun 2024	11
13	AsKC11, a Kunitz Peptide from Anemonia sulcata, Is a Novel Activator of G Protein-Coupled Inward-Rectifier Potassium Channels Dongchen An, Ernesto Lopes Pinheiro-Júnior, László Béress et al. · Marine Drugs Open access	15 Feb 2022	10
14	Interaction between bradykinin and natriuretic peptides via RGS protein activation in HEK-293 cells Marina Dobrivojević, Aleksandra Sinđić, Bayram Edemir et al. · American Journal of Physiology-Cell Physiology	11 Oct 2012	10
15	Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates Hans H. Wellhöner, Aryeh M. Weiss, Axel Ronald Schulz et al. · Journal of drug targeting	14 May 2012	7
16	Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis Tim Moderer, Ioana Puşcalău-Gîrţu, Christian Haupt et al. · Amyloid Open access	11 Jul 2023	6
17	A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements Julia Eberle, Rahel Stefanie Wiehe, Boris Gole et al. · Frontiers in Oncology Open access	18 Jun 2021	3
18	Natriuretic peptides in brain physiology Aleksandra Sinđić, Marina Dobrivojević, Jochen R. Hirsch · Translational Neuroscience Open access	Sep 2011	3
19	LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis model Pascal Canbolat, Jenny Wilzopolski, Sabine Kaessmeyer et al. · Journal of Dermatological Science Open access	13 Mar 2024	2
20	Modeling chromatographic purification of rh-bFGF with Heparin HyperD affinity sorbent using a homogeneous and a pore diffusion model Gunnar Garke, Wolf‐Dieter Deckwer, Friedrich Birger Anspach · Separation Science and Technology	28 May 2002	1
21	EPI-X4 is a peptide antagonist of CXCR4 with therapeutic prospects for cancer and inflammatory disorders Micah N. Sagini, Martin Reinhold Berger, Jürgen Muthmann et al. · Peptides	21 Feb 2026	0
22	LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis model Wolfgang Bäumer, Pascal Canbolat, Jenny Wilzopolski et al. PreprintOpen access	17 Apr 2023	0
23	Sulfate limitation increases specific plasmid DNA yield and productivity in E. coli fed-batch processes Mathias Gotsmy, Florian Strobl, Florian Weiß et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	9 Feb 2023	0
24	A novel E. coli strain shows controllable leakiness for extracellular production of recombinant proteins Jens Kastenhofer, Lukas A. Rettenbacher, Lukas Feuchtenhofer et al. PreprintOpen access	28 Apr 2020	0
25	Triggering outer membrane leakiness of a novel E. coli strain for recombinant protein production Jens Kastenhofer, Lukas A. Rettenbacher, Lukas Feuchtenhofer et al. PreprintOpen access	8 Apr 2020	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.